Microalbuminuria as a potential novel cardiovascular biomarker in patients with COPD
暂无分享,去创建一个
[1] P. Romundstad,et al. COPD and microalbuminuria: a 12-year follow-up study , 2014, European Respiratory Journal.
[2] C. Delles,et al. Proteinuria and its relation to cardiovascular disease , 2013, International journal of nephrology and renovascular disease.
[3] A. Folsom,et al. Classical and Novel Biomarkers for Cardiovascular Risk Prediction in the United States , 2013, Journal of epidemiology.
[4] Bernadette A. Thomas,et al. Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010 , 2012, The Lancet.
[5] U. Kisa,et al. Microalbuminuria in Chronic Obstructive Pulmonary Disease , 2012, COPD.
[6] F. Martinez,et al. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary. , 2007, American journal of respiratory and critical care medicine.
[7] S. Sharma,et al. Cardiovascular and renal effects of chronic exposure to high altitude. , 2012, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.
[8] Zahi A Fayad,et al. 2010 ACCF/AHA guideline for assessment of cardiovascular risk in asymptomatic adults: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. , 2010, Circulation.
[9] M. Budoff,et al. 2010 ACCF/AHA Guideline for Assessment of Cardiovascular Risk in Asymptomatic Adults: Executive Summary , 2010 .
[10] B. Celli,et al. Microalbuminuria and hypoxemia in patients with chronic obstructive pulmonary disease. , 2010, American journal of respiratory and critical care medicine.
[11] S. Yusuf,et al. Telmisartan, ramipril, or both in patients at high risk for vascular events. , 2008, The New England journal of medicine.
[12] Ç. Yenisey,et al. Microalbuminuria, von Willebrand factor and fibrinogen levels as markers of the severity in COPD exacerbation , 2008, Journal of Thrombosis and Thrombolysis.
[13] Bartolome Celli,et al. Salmeterol and fluticasone propionate and survival in chronic obstructive pulmonary disease. , 2007, The New England journal of medicine.
[14] P. Palatini,et al. Glomerular hyperfiltration predicts the development of microalbuminuria in stage 1 hypertension: the HARVEST. , 2006, Kidney international.
[15] P. Hildebrandt,et al. N-terminal pro-brain natriuretic peptide, C-reactive protein, and urinary albumin levels as predictors of mortality and cardiovascular events in older adults. , 2005, JAMA.
[16] A. Iskandrian,et al. Brachial artery reactivity in asymptomatic patients with type 2 diabetes mellitus and microalbuminuria (from the Detection of Ischemia in Asymptomatic Diabetics-brachial artery reactivity study). , 2004, The American journal of cardiology.
[17] G. Cerasola,et al. Relationship between albumin excretion rate and aortic stiffness in untreated essential hypertensive patients , 2004, Journal of internal medicine.
[18] K. Kohara,et al. Microalbuminuria and arterial stiffness in a general population: the Shimanami Health Promoting Program (J-SHIPP) study. , 2004, Hypertension research : official journal of the Japanese Society of Hypertension.
[19] G. Tibet,et al. Microalbuminuria in chronic obstructive pulmonary disease. , 2003, Monaldi archives for chest disease = Archivio Monaldi per le malattie del torace.
[20] S. Romundstad,et al. Microalbuminuria and all-cause mortality in 2,089 apparently healthy individuals: a 4.4-year follow-up study. The Nord-Trøndelag Health Study (HUNT), Norway. , 2003, American journal of kidney diseases : the official journal of the National Kidney Foundation.
[21] A. Cogo,et al. Proteinuria in COPD patients with and without respiratory failure. , 2003, Chest.
[22] Alan D. Lopez,et al. The Global Burden of Disease Study , 2003 .
[23] S. Antoniu,et al. Hospitalizations and mortality in the Lung Health Study , 2002, Expert review of pharmacoeconomics & outcomes research.
[24] R. Pauwels,et al. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease. NHLBI/WHO Global Initiative for Chronic Obstructive Lung Disease (GOLD) Workshop summary. , 2001, American journal of respiratory and critical care medicine.
[25] D. Levy,et al. Prediction of coronary heart disease using risk factor categories. , 1998, Circulation.